Table 3.
Details of HIV exposure surveillance activities reported by health departments in 33 jurisdictions that conducted perinatal HIV exposure surveillance and reporting, United States, 2014a
| Perinatal HIV Exposure Surveillance Activities | Jurisdictions (n = 33), No. b (%) |
|---|---|
| When did your jurisdiction initiate perinatal HIV exposure reporting? | |
| Within the last 12 mo | 1 (3) |
| 1-3 y ago | 1 (3) |
| 3-5 y ago | 4 (12) |
| >5 y ago | 27 (82) |
| What methods are used to identify HIV-exposed infants? | |
| Laboratory reports | 30 (91) |
| Reports from health care providers | 25 (76) |
| HIV, specialty clinic, or other adult providers | 21 (64) |
| Pediatric providers | 20 (61) |
| Obstetricians/gynecologists | 9 (27) |
| Other medical providers | 9 (27) |
| Birth hospital reports | 20 (61) |
| Vital statistics (birth registry matches) | 16 (48) |
| Newborn testing | 13 (39) |
| How is the infant’s HIV infection status determined? | |
| Laboratory reporting | 27 (82) |
| Medical record review | 20 (61) |
| Other | 4 (12) |
| Not specified | 4 (12) |
| Is your jurisdiction able to link an infant’s case report to the mother’s case report? | |
| Can link all infants | 21 (64) |
| Can link some infants | 7 (21) |
| Can link only HIV-infected infants | 3 (9) |
| Cannot link infants | 1 (3) |
| Missing response | 1 (3) |
| Does your jurisdiction have a mechanism to determine the HIV care status of postpartum women? | |
| Yes | 12 (36) |
| No | 21 (64) |
| What mechanisms are used to determine the HIV care status of postpartum women? | |
| Laboratory reporting | 8 (24) |
| Medical record review | 5 (15) |
| Other | 5 (15) |
| Not specified | 1 (3) |
| Do not follow women postpartum | 21 (63) |
| What data collection tools are used for perinatal HIV exposure reporting? | |
| Pediatric Case Report Form | 30 (91) |
| Adult Case Report Form | 14 (42) |
| Perinatal HIV Exposure Report Form | 7 (21) |
| Enhanced Perinatal Surveillance form | 5 (15) |
| Jurisdiction-created tool | 8 (24) |
| What databases are used for perinatal HIV exposure data? | |
| Enhanced HIV/AIDS Reporting System | 31 (94) |
| Enhanced Perinatal Surveillance System | 4 (12) |
| Other database | 12 (36) |
| How are perinatal HIV exposure data disseminated? | |
| Epidemiologic profile | 19 (58) |
| Larger surveillance annual report | 16 (48) |
| National and international conferences | 6 (18) |
| State and local presentations | 4 (12) |
| Perinatal annual report | 4 (12) |
| Website | 4 (12) |
| Peer-reviewed journals | 3 (9) |
| Perinatal data are not reported | 4 (12) |
| Missing response | 3 (9) |
Abbreviation: HIV, human immunodeficiency virus.
aActivities reported by 33 jurisdictions that conducted perinatal HIV exposure surveillance, in an online survey disseminated to 59 HIV surveillance contacts in health departments directly funded for HIV surveillance by the Centers for Disease Control and Prevention, including all 50 US states, District of Columbia, Puerto Rico, Virgin Islands, and 6 cities and counties (Chicago, Illinois; Houston, Texas; Los Angeles, CA; New York City; Philadelphia, PA; and San Francisco, CA).
bNumbers do not total to 33, because respondents could choose >1 option.